EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Prevalence and risk factors of metabolic dysfunction‐associated steatotic liver disease in south Central Uganda: A cross‐sectional survey

Rocio Enriquez, Mahmoud Homsi, Robert Ssekubugu, Dorean Nabukalu, Zangin Zeebari, Gaetano Marrone, Bruna Gigante, Larry W Chang, Steven J Reynolds, Fred Nalugoda, Anna Mia Ekström, Hannes Hagström iD und 1 weitere

Alimentary Pharmacology & Therapeutics · 2024

DOI: 10.1111/apt.17931 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alimentary Pharmacology & Therapeutics, 2024. Verfasst von Rocio Enriquez und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: HIV Infections, Metabolic Diseases, Fatty Liver, Cardiovascular Diseases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: CDC HHS, NIMH NIH HHS, NICHD NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Despite numerous risk factors and serious consequences, little is known about metabolic dysfunction‐associated steatotic liver disease (MASLD) at population level in Africa.

Aim

The aim of the study was to estimate the prevalence and risk factors of MASLD in people living with and without HIV in Uganda.

Methods

We collected data from 37 communities in South Central Uganda between May 2016 and May 2018. We estimated MASLD prevalence using the fatty liver index and advanced liver fibrosis using the dynamic aspartate‐to‐alanine aminotransferase ratio. We collected additional data on sociodemographics, HIV and cardiovascular disease (CVD) risk factors. We used multivariable logistic regression to determine the association between HIV, CVD risk factors and MASLD.

Results

We included 759 people with HIV and 704 HIV‐negative participants aged 35–49. MASLD prevalence was 14% in women and 8% in men; advanced liver fibrosis prevalence was estimated to be

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsMetabolic DiseasesFatty LiverCardiovascular DiseasesMaleFemaleHumansCross-Sectional StudiesUgandaPrevalenceRisk FactorsLiver CirrhosisAspartate Aminotransferases

Stichwörter der Autor:innen

HIVmetabolic dysfunction‐associated steatotic liver diseasemetabolic syndromesub‐Saharan Africa

Substanzen

Aspartate Aminotransferases

Autor:innen und Institutionen

  • Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden.
  • Rakai Health Sciences Program, Kalisizo, Uganda.
  • Jönköping International Business School, Jönköping University, Jönköping, Sweden.
  • Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.
  • Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Division of Infectious Diseases, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.

ORCID-Profile: Hannes Hagström, Helena Nordenstedt

Förderung

  • CDC HHS
  • NIMH NIH HHS
  • NICHD NIH HHS
  • NIAID NIH HHS
  • National Center for Child Health and Development
  • National Institute of Allergy and Infectious Diseases
  • Vetenskapsrådet
  • Centers for Disease Control and Prevention

Zitieren

APA

Enriquez, R., Homsi, M., Ssekubugu, R., Nabukalu, D., Zeebari, Z., Marrone, G., Gigante, B., Chang, L. W., Reynolds, S. J., Nalugoda, F., Ekström, A. M., Hagström, H., & Nordenstedt, H. (2024). Prevalence and risk factors of metabolic dysfunction‐associated steatotic liver disease in south Central Uganda: A cross‐sectional survey. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.17931

Vancouver

Enriquez R, Homsi M, Ssekubugu R, Nabukalu D, Zeebari Z, Marrone G, et al. Prevalence and risk factors of metabolic dysfunction‐associated steatotic liver disease in south Central Uganda: A cross‐sectional survey. Alimentary Pharmacology & Therapeutics. 2024. doi:10.1111/apt.17931

BibTeX
@article{Enriquez2024,
  author = {Enriquez, Rocio and Homsi, Mahmoud and Ssekubugu, Robert and Nabukalu, Dorean and Zeebari, Zangin and Marrone, Gaetano and Gigante, Bruna and Chang, Larry W and Reynolds, Steven J and Nalugoda, Fred and Ekström, Anna Mia and Hagström, Hannes and Nordenstedt, Helena},
  title = {Prevalence and risk factors of metabolic dysfunction‐associated steatotic liver disease in south Central Uganda: A cross‐sectional survey},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2024},
  doi = {10.1111/apt.17931}
}
Kostenlos starten →